Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Adaptive Biotechnologies Corp's President and COO sold 57,180 shares between March 24 and March 26, 2026 under a pre-arranged 10b5-1 plan, generating about $802,235. She simultaneously exercised options to acquire 44,166 shares at $7.27 apiece for $321,086. The company recently reported stronger-than-expected fourth-quarter 2025 results and receive…
At the Conservative Political Action Conference in Grapevine, Texas, Republican speakers and many attendees voiced strong support for recent U.S. strikes on Iran, aligning with President Donald Trump even as national approval of the president has slipped and voters express unease about the conflict and rising fuel costs. The pro-war tone at CPAC co…
Rubrik Chief Financial Officer Choudary Kiran Kumar sold 122,613 Class A shares on March 24, 2026, generating $5.91 million, and converted 212,188 Class B shares to Class A the same day. The transaction occurred while the stock traded near a 52-week low. Separately, Rubrik reported quarterly results and guidance that topped FactSet consensus and in…
Anthropic executives have discussed taking the AI startup public as soon as the fourth quarter of 2026, with bankers pitching plans that could raise more than $60 billion. The potential IPO arrives amid a broader push by large AI developers to access public capital, and against a backdrop of market liquidity worries tied to persistent inflation and…
Rubrik Chief Technology Officer Arvind Nithrakashyap sold 28,967 shares of Class A common stock on March 24, 2026, for $48.1957 per share, netting $1,396,084. The same day he converted 40,625 Restricted Stock Units into shares at no cost. The stock is trading close to its 52-week low, while the company has reported quarterly results and forward gui…
David Raben, chief medical officer of Bicara Therapeutics Inc (NASDAQ: BCAX), sold 5,500 shares of the company's common stock on March 25, 2026, for about $104,229 while simultaneously exercising options to acquire an equal number of shares at a substantially lower strike. The transactions occurred just days ahead of Bicara's March 30 earnings repo…
The Trump administration announced plans to vacate the Education Department's Lyndon B. Johnson headquarters in Washington, relocating the agency to a smaller office within the capital while the Department of Energy will occupy the LBJ building. Officials described the shift as a cost-saving reorganization as the administration continues steps to r…
Russian defence officials reported the capture of Sheviakivka in Kharkiv region as part of a measured advance, while a Ukrainian airborne unit said it had retaken Berezove in Dnipropetrovsk region. Independent confirmation of either claim was not available. Both sides continue to position for wider operations amid stalled peace talks and concerns a…
Roberto Perli, who oversees implementation of monetary policy at the Federal Reserve Bank of New York, indicated that the central bank's large-scale Treasury bill purchases - currently about $40 billion per month - are likely to be scaled back after the April 15 tax-payment date. Perli said the reduction could be gradual to reflect uncertainty arou…
Federal Reserve Governor Michael Barr said a sustained rise in oil and commodity prices tied to the Iran conflict could lift inflation expectations, complicating the Fed's path to easing monetary policy. He urged patience in any rate reductions and expressed concern that recent supervisory changes have weakened banking system resilience.
The U.S. Census Bureau reported a deceleration in population growth across metropolitan areas for the 12 months ending July 1, 2025, with the average metro increase falling to 0.6% from 1.1% the previous year. Overall U.S. population rose by 1.8 million in the same period. The steepest metro slowdowns occurred in Laredo, Texas; Yuma, Arizona; and E…
DXP Enterprises director Timothy P. Halter sold 5,000 shares of the company’s common stock on March 26, 2026, at $139.57 per share, yielding $697,850. The transaction occurred while the stock traded near $137.06 after a roughly 60% gain over the prior year. The company reported mixed fourth-quarter fiscal 2025 results, missing EPS expectations but …
A surge of retail trading in South Korea has helped lift the KOSPI to extraordinary gains over six months and driven record participation and balances, while recent Middle East conflict and a historic single-day drop have tested investor resolve. Despite volatility, individual investors have increased activity and deposits, motivated by income conc…
Federal Reserve Vice Chair Philip Jefferson warned that persistent increases in energy prices could push inflation higher and weigh on consumer and business spending, creating a difficult trade-off for policymakers. Speaking at a Dallas Fed event, Jefferson said the Fed's policy is "appropriately positioned" to support the labor market while inflat…
Magnetar Financial LLC, a 10% stakeholder in Wheeler Real Estate Investment Trust, sold 8,840 shares of WHLR common stock on March 26, 2026, at a weighted average price of $1.0964 for a total of $9,692. The transaction follows a March 24 acquisition of 172,075 shares at $0.01 and the disposition of a matching number of warrants. The sale and owners…
Definium Therapeutics Chief Legal Officer Mark Sullivan sold 10,702 common shares on March 25, 2026, under a Rule 10b5-1 plan to satisfy withholding tax obligations tied to vested restricted stock units. The transaction generated $197,665 at a weighted average price of $18.47 per share. Definium's recent fourth-quarter 2025 results showed heavy inv…
Definium Therapeutics Chief Executive Officer Robert Barrow sold 24,431 shares on March 25, 2026, for about $451,240 at weighted average prices between $18.36 and $18.80. The transaction, made under a Rule 10b5-1 plan adopted in 2022, was executed to meet withholding tax obligations related to vested restricted stock units. The stock is trading nea…
Definium Therapeutics, Inc. (NASDAQ:DFTX) Chief Medical Officer Daniel Karlin sold 8,018 shares on March 25, 2026, under a Rule 10b5-1 sell-to-cover election to satisfy withholding tax obligations. The transaction totaled $148,092 at a weighted average price of $18.47. Separately, the company reported fourth-quarter 2025 results showing a meaningfu…
President Donald Trump announced a 10-day halt to U.S. attacks on Iranian energy infrastructure at Tehran’s request and described negotiations as progressing well, while Iranian officials called a U.S. peace proposal unfair. The conflict has caused thousands of deaths, disrupted global energy and shipping markets, and prompted continued strikes acr…
On March 26, the Department of Homeland Security Inspector General initiated a probe into how certain contracts were solicited and managed, including the reported participation of former DHS Secretary Kristi Noem and her aide Corey Lewandowski, sources told CNN. The probe is distinct from an ongoing inspector general audit of DHS grants and contrac…
Director Kamal Seyed Ghaffarian and related entities sold 283,818 Class A shares of Intuitive Machines (NASDAQ: LUNR) on March 24, 2026, for roughly $5.3 million under a Rule 10b5-1 plan. The trades, executed across several price points, coincided with a stock that has climbed 119% over the past year. The company also disclosed a major NASA payload…
OpenAI said its U.S. advertising pilot for ChatGPT reached an annualized revenue run-rate above $100 million within six weeks of launch. The company reported broad user eligibility, growing advertiser interest and plans to roll the test out to additional countries, while emphasizing that ads are kept separate from model outputs and user conversatio…
Paula Soteropoulos, a member of Dianthus Therapeutics' board, sold 27,594 shares on March 24, 2026, for $78.05 each, generating $2.15 million in proceeds. On the same day she exercised options to acquire the same number of shares at $8.44 per share, costing $232,893. The company recently completed a sizable public offering that raised approximately…
XORTX Therapeutics Inc. announced the results of its annual and special shareholders meeting held on March 24, 2026. Key approvals included election of all five board nominees, appointment of auditors, re-approval of the stock option plan, and authorization of share consolidation. The company focuses on developing treatments for gout and progressiv…
Russell Low, President and CEO of Axcelis Technologies Inc (NASDAQ: ACLS), sold 1,244 shares on March 24, 2026, under a Rule 10b5-1 plan established in December 2025. The transaction totaled $111,960 at $90.00 per share. Axcelis reported stronger-than-expected fourth-quarter results but issued first-quarter guidance below analyst expectations. Conc…
